Nierenberg Investment Management Company, Inc. Cytom X Therapeutics, Inc. Transaction History
Nierenberg Investment Management Company, Inc.
- $180 Million
- Q4 2024
A detailed history of Nierenberg Investment Management Company, Inc. transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Nierenberg Investment Management Company, Inc. holds 12,555 shares of CTMX stock, worth $9,416. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,555
Previous 12,555
-0.0%
Holding current value
$9,416
Previous $14,000
14.29%
% of portfolio
0.01%
Previous 0.01%
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $49.5M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...